Datopotamab Deruxtecan (Dato-DXd) for Non-Small Cell Lung Cancer (NSCLC) Patients With Active Brain Metastases

Clinical trial NCT06676917 · WITHDRAWN

Trial details

NCT number: NCT06676917
Sponsor: MedSIR
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2025-06-01
Primary completion: 2027-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.